Structure via PubChem · Public domain (PubChem)
brecanavir
Sign in to saveAlso known as BCV
Brecanavir (INN; codenamed GW640385) is a protease inhibitor which has been studied for the treatment of HIV.
In the Vinony graph
Within Vinony's link graph, brecanavir is referenced by 126 other articles, and connects out to tenofovir alafenamide, nucleoside analogue and medication.
It is catalogued under topics including Abandoned drugs, Benzodioxoles and Carbamates.
Its subject is documented across 5 Wikipedia language editions.
Chemical data
- Formula
- C33H41N3O10S2
- Molecular weight
- 703.8 g/mol
- IUPAC name
- [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[1,3-benzodioxol-5-ylsulfonyl(2-methylpropyl)amino]-3-hydroxy-1-[4-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl]butan-2-yl]carbamate
- SMILES
- CC1=NC(=CS1)COC2=CC=C(C=C2)C[C@@H]([C@@H](CN(CC(C)C)S(=O)(=O)C3=CC4=C(C=C3)OCO4)O)NC(=O)O[C@H]5CO[C@@H]6[C@H]5CCO6
- InChIKey
- JORVRJNILJXMMG-OLNQLETPSA-N
- XLogP
- 4.4
- Polar surface area
- 192 Ų
- H-bond donors
- 2
- H-bond acceptors
- 13
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
- Indications
- HIV-1 infection, HIV infection
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 703.223
Show 3 more facts
- chemical formula
- C₃₃H₄₁N₃O₁₀S₂
- canonical SMILES
- CC1=NC(=CS1)COC2=CC=C(C=C2)CC(C(CN(CC(C)C)S(=O)(=O)C3=CC4=C(C=C3)OCO4)O)NC(=O)OC5COC6C5CCO6
- isomeric SMILES
- CC1=NC(=CS1)COC2=CC=C(C=C2)C[C@@H]([C@@H](CN(CC(C)C)S(=O)(=O)C3=CC4=C(C=C3)OCO4)O)NC(=O)O[C@H]5CO[C@@H]6[C@H]5CCO6
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
2 sectionsContents
- See also
- References
Brecanavir (INN; codenamed GW640385) is a protease inhibitor which has been studied for the treatment of HIV.
In December 2006, its developer, GlaxoSmithKline discontinued further development because of insurmountable issues regarding formulation.
Excerpted from Wikipedia’s “brecanavir” article, available under the CC BY-SA 4.0 licence.